Atlas Trials

Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study

Clinical trial NCT01502397 · COMPLETED

Trial details

NCT number
NCT01502397
Sponsor
The University of Hong Kong
Status
COMPLETED
Study type
OBSERVATIONAL
Exposure to Hepatitis B Virus
Start date
2011-12-01
Primary completion
2015-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.